Trial intelligence / Profile preview

Hepatic Function Evaluation Using Gadoxetic Acid Enhanced MRI

NCT02854371Phase 4Completed

Sponsor
Seoul National University Hospital
Start
Aug 2016
Primary completion
Feb 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of gadoxetate disodium in chronic liver disease (CLD), Cirrhosis, sponsored by Seoul National University Hospital. Started Aug 2016; status: completed.

02

Drugs

gadoxetate disodium
03

Conditions

chronic liver disease (CLD)Cirrhosis

Beyond the preview

Go deeper on NCT02854371.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02854371.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call